McElroy, Susan L <br/><br/>
A double-blind, placebo-controlled study of quetiapine and paroxetine as monotherapy in adults with bipolar depression (EMBOLDEN II).  [electronic resource] 

 -  The Journal of clinical psychiatry  Feb 2010 
 - 163-74 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1555-2101 
<br/><br/><label>Standard No.: </label>10.4088/JCP.08m04942gre  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Aged<br/>Antidepressive Agents--adverse effects<br/>Antidepressive Agents, Second-Generation--adverse effects<br/>Antimanic Agents--adverse effects<br/>Bipolar Disorder--drug therapy<br/>Dibenzothiazepines--adverse effects<br/>Double-Blind Method<br/>Female<br/>Humans<br/>Male<br/>Middle Aged<br/>Paroxetine--adverse effects<br/>Placebos<br/>Psychiatric Status Rating Scales<br/>Quetiapine Fumarate<br/>Severity of Illness Index<br/>Treatment Outcome